Infections and Chlamydia pneumoniae antibodies influence the functional outcome in thrombolysed strokes-Reference-Cited by-同舟云学术

Infections and Chlamydia pneumoniae antibodies influence the functional outcome in thrombolysed strokes

Published:2017-10 Issue: Volume:381 Page:95-99
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Consoli Domenico,Vidale Simone,Arnaboldi Marco,Cavallini Anna,Consoli Arturo,Galati Franco,Guidetti Donata,Micieli Giuseppe,Rasura Maurizia,Sterzi Roberto,Toni Danilo,Inzitari Domenico

Funder

Italian Ministry of Health.

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference28 articles.

1. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study;Wahlgren;Lancet,2007

2. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischemic stroke: a meta-analysis iof individual patient data from randomised trials;Emberson;Lancet,2014

3. Poststroke infections are an independent risk factor for poor functional outcome after three-months in thrombolysed stroke patients;Rocco;Int. J. Stroke,2013

4. Routine serum C-reactive protein and stroke outcome after intravenous thrombolysis;Karlinski;Acta Neurol. Scand.,2014

5. Seropositivity to Chlamydia pneumoniae is associated with risk of first ischemic stroke;Elkind;Stroke,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal analysis of quality of life in primary lung cancer patients with chlamydia pneumoniae infection: a time-to-deterioration model;BMC Pulmonary Medicine;2024-01-17

2. Longitudinal analysis of quality of life in primary lung cancer patients with chlamydia pneumoniae infection: a time-to-deterioration model;2023-08-14

3. Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19;Neurology;2022-11-09

4. Pivotal Pathogenic and Biomarker Role of Chlamydia Pneumoniae in Neurovascular Diseases;Current Neurovascular Research;2018-10-18

5. The Role of Inflammation in Neurological Disorders;Current Pharmaceutical Design;2018-07-13